Tong Liu

Title: Innovations in Blood Group Genotyping by Tong Liu

Introduction

Tong Liu is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of blood group genotyping, particularly through his innovative methods and kits that utilize next-generation sequencing technology.

Latest Patents

Tong Liu holds a patent for a "Method and kit for genotyping of multi-system red blood cell (RBC) blood group based on next-generation sequencing (NGS)." This invention provides a method and a kit that enable the rapid genotyping of 17 RBC blood group systems and multiple key rare blood groups. The technology employs multiplex PCR capture primer sets and amplification reaction conditions designed for the Illumina platform. This allows for the simultaneous detection of full-length coding regions and spliced flanking regions of 25 blood group genes across three reactions. The method boasts high detection efficiency and low average costs, overcoming limitations of existing blood group gene detection technologies.

Career Highlights

Tong Liu is associated with the Shenzhen Blood Center, where he applies his expertise in blood group genotyping. His work has been instrumental in advancing the capabilities of blood group gene detection, providing comprehensive and accurate results that include both known and unknown mutation sites.

Collaborations

Tong Liu collaborates with notable colleagues such as Shuang Liang and Jinfeng Zeng, contributing to the advancement of research in blood group genotyping.

Conclusion

Tong Liu's innovative work in blood group genotyping represents a significant advancement in medical technology. His contributions are paving the way for more efficient and accurate blood group detection methods.